439 related articles for article (PubMed ID: 25670883)
1. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics.
Ahmed OA; Hosny KM; Al-Sawahli MM; Fahmy UA
Drug Des Devel Ther; 2015; 9():655-62. PubMed ID: 25670883
[TBL] [Abstract][Full Text] [Related]
2. Optimized zein nanospheres for improved oral bioavailability of atorvastatin.
Hashem FM; Al-Sawahli MM; Nasr M; Ahmed OA
Int J Nanomedicine; 2015; 10():4059-69. PubMed ID: 26150716
[TBL] [Abstract][Full Text] [Related]
3. Solubility enhancement of simvastatin: a review.
Murtaza G
Acta Pol Pharm; 2012; 69(4):581-90. PubMed ID: 22876598
[TBL] [Abstract][Full Text] [Related]
4. Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.
Hashem FM; Al-Sawahli MM; Nasr M; Ahmed OA
Drug Des Devel Ther; 2015; 9():3141-52. PubMed ID: 26150693
[TBL] [Abstract][Full Text] [Related]
5. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
Nagaraj K; Narendar D; Kishan V
Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of Luteolin Loaded Zein-Caseinate Nanoparticles and its Bioavailability Enhancement in Rats.
Xu QT; Zhang WX; Xu HX; Zhang QF
J Pharm Sci; 2023 Dec; 112(12):3056-3066. PubMed ID: 37356712
[TBL] [Abstract][Full Text] [Related]
7. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
Mandpe L; Pokharkar V
Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
[TBL] [Abstract][Full Text] [Related]
8. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
[TBL] [Abstract][Full Text] [Related]
9. G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin.
Qi R; Zhang H; Xu L; Shen W; Chen C; Wang C; Cao Y; Wang Y; van Dongen MA; He B; Wang S; Liu G; Banaszak Holl MM; Zhang Q
Nanomedicine; 2015 Jul; 11(5):1141-51. PubMed ID: 25791813
[TBL] [Abstract][Full Text] [Related]
10. Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation.
Fahmy UA
Drug Des Devel Ther; 2015; 9():6129-37. PubMed ID: 26604700
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the Hypolipidemic Effect of Simvastatin in Poloxamer-Induced Hyperlipidemic Rats via Liquisolid Approach: Pharmacokinetic and Pharmacodynamic Evaluation.
El-Say KM; Ahmed TA; Ahmed OAA; Elimam H
AAPS PharmSciTech; 2020 Aug; 21(6):223. PubMed ID: 32749629
[TBL] [Abstract][Full Text] [Related]
12. Preparation and statistical optimization of alginate based stomach specific floating microcapsules of simvastatin.
Premchandani TA; Barik BB
Acta Pol Pharm; 2012; 69(4):751-61. PubMed ID: 22876619
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability Enhancement of Astilbin in Rats through Zein-Caseinate Nanoparticles.
Zheng D; Zhang QF
J Agric Food Chem; 2019 May; 67(20):5746-5753. PubMed ID: 31045359
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
Gu F; Ning J; Fan H; Wu C; Wang Y
Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479
[TBL] [Abstract][Full Text] [Related]
15. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
16. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.
Lai J; Chen J; Lu Y; Sun J; Hu F; Yin Z; Wu W
AAPS PharmSciTech; 2009; 10(3):960-6. PubMed ID: 19636709
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and characterization of dihydromyricetin encapsulated zein-caseinate nanoparticles and its bioavailability in rat.
Sun CC; Su H; Zheng GD; Wang WJ; Yuan E; Zhang QF
Food Chem; 2020 Nov; 330():127245. PubMed ID: 32521399
[TBL] [Abstract][Full Text] [Related]
18. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
20. Fabrication, characterization and antimicrobial activities of thymol-loaded zein nanoparticles stabilized by sodium caseinate-chitosan hydrochloride double layers.
Zhang Y; Niu Y; Luo Y; Ge M; Yang T; Yu LL; Wang Q
Food Chem; 2014 Jan; 142():269-75. PubMed ID: 24001841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
